BioMed Research International / 2017 / Article / Tab 2

Research Article

Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation

Table 2

Univariate analysis of the correlation between demographic and clinicopathological characteristics and survival time in patients with MM.

CharacteristicsOS (mean)PFS (mean)

Age≥6010020.35516.595
<608128.23320.102
GenderMale11423.61418.322
Female6724.33317.897
Ig isotypeIgG9722.53116.210
IgA4724.41919.674
Light chain3121.91418.971
Others651.64533.772
ISS stagingI3129.09622.806
II8628.49021.231
III6415.16111.796
ECOG0-115325.09818.830
2–42817.23014.531
Plt (×109/L)≥10015625.25119.403
<1002515.32710.440
Hb (g/L)≥1005522.73221.187
<10012626.51116.846
Scr (μmol/L)≥1773913.88810.382
<17714226.62520.302
Serum Alb (g/L)≥354925.29220.049
<3513223.35717.465
Serum -MG (μmol/L)≥5.56415.16111.796
<5.511728.65021.648
Serum LDH (IU/L)≥2452818.71714.700
<24515324.82618.799
Serum Ca (mmol/L)≥2.752113.26811.910
<2.7516025.27318.986
BortezomibYes11124.81618.957
No7022.39816.909
ThalidomideYes14426.71220.368
No3712.8609.590
Blood transfusionYes6822.37614.998
No11324.78620.070